Genscript Biotech Corporation GNNSF
Set alert
4.50 USD 0.00 0.00%
At close · Oct 30
4.38 Day range 4.38
1.30 52-week range 6.55
- YTD
- +171.08%
- 1 year
- +109.30%
- Open
- 4.38
- Prev close
- 4.50
- Mkt cap
- 10.26B
- Vol
- 400
- Avg vol
- 1.36K
- EPS
- -0.29
- P/E
- 0.00
More statistics
- Low
- 4.38
- High
- 4.38
2Y chart
Events in this range
- Mar 11, 2025Earnings: 1.48; estimate -0.01; surprise 14900%
Signals (63)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 15, 2026 | 2 weeks ago |
| MACD: Sell Signal | Oct 8, 2026 | 3 weeks ago |
| RSI: Overbought | Oct 5, 2026 | 3 weeks ago |
| RSI: Overbought | Sep 30, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 21, 2026 | 1 month ago |
| RSI: Overbought | Sep 18, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 4, 2026 | 1 month ago |
| SMA: Bullish | Jul 20, 2026 | 3 months ago |
| SMA: Bullish | Jul 20, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 20, 2026 | 3 months ago |
| RSI: Overbought | Jul 20, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 9, 2026 | 3 months ago |
| RSI: Oversold | Jul 9, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 6, 2026 | 3 months ago |
| RSI: Overbought | May 29, 2026 | 5 months ago |
| MACD: Sell Signal | May 26, 2026 | 5 months ago |
| SMA: Bullish | May 4, 2026 | 6 months ago |
| RSI: Overbought | May 4, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 2, 2026 | 7 months ago |
| RSI: Oversold | Mar 31, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 9, 2026 | 7 months ago |
| RSI: Oversold | Mar 9, 2026 | 7 months ago |
| MACD: Buy Signal | Feb 20, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 9, 2026 | 8 months ago |
| RSI: Oversold | Feb 9, 2026 | 8 months ago |
| MACD: Buy Signal | Jan 13, 2026 | 9 months ago |
| SMA: Bearish | Dec 29, 2025 | 10 months ago |
| RSI: Oversold | Dec 29, 2025 | 10 months ago |
| SMA: Bearish | Dec 2, 2025 | 11 months ago |
| MACD: Sell Signal | Dec 2, 2025 | 11 months ago |
| SMA: Bullish | Nov 14, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 7, 2025 | 11 months ago |
| RSI: Oversold | Oct 31, 2025 | 1 year ago |
| SMA: Bearish | Oct 9, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 22, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 15, 2025 | 1 year ago |
| RSI: Overbought | Sep 15, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 20, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 6, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 31, 2025 | 1 year ago |
| RSI: Overbought | Jul 24, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 23, 2025 | 1 year ago |
| SMA: Bullish | Jul 18, 2025 | 1 year ago |
| SMA: Bearish | Jul 11, 2025 | 1 year ago |
| RSI: Oversold | Jul 11, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 27, 2025 | 1 year ago |
| SMA: Bullish | Jun 4, 2025 | 1 year ago |
| RSI: Overbought | Jun 4, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 29, 2025 | 1 year ago |
| RSI: Oversold | Apr 9, 2025 | 1 year ago |
| SMA: Bullish | Apr 4, 2025 | 1 year ago |
| SMA: Bearish | Mar 31, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 31, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 18, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 4, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 21, 2025 | 1 year ago |
| RSI: Overbought | Feb 21, 2025 | 1 year ago |
| SMA: Bullish | Feb 18, 2025 | 1 year ago |
| SMA: Bearish | Feb 13, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 13, 2025 | 1 year ago |
| RSI: Overbought | Feb 4, 2025 | 1 year ago |
| SMA: Bullish | Jan 23, 2025 | 1 year ago |
| RSI: Oversold | Dec 30, 2024 | 1 year ago |
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Mar 15, 2026 | Dec 31, 2025 | -0.03 | -0.23 | -0.20 | -666.67% |
| Aug 17, 2025 | Jun 30, 2025 | 0.08 | -0.0216 | -0.10 | -127.00% |
| Mar 11, 2025 | Dec 31, 2024 | -0.01 | 1.48 | +1.49 | +14,900.00% |
| Aug 9, 2024 | Jun 30, 2024 | -0.01 | -0.0827 | -0.07 | -727.00% |
| Mar 10, 2024 | Dec 31, 2023 | -0.05 | -0.032 | +0.02 | +36.00% |
News
- Genscript Biotech Corporation (GNNSF) Q2 2026 Earnings Call Transcript
- Genscript Biotech Corporation (GNNSF) Q4 2025 Earnings Call Transcript
- GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality Growth
- Genscript Biotech Corporation (GNNSF) Q2 2025 Earnings Call Transcript
- GenScript Biotech Demonstrates Profitable Scale and Strategic Leadership in H1 2025, Establishing Clear Industry Leadership Through Accelerated Growth and Innovation
- GenScript Biotech's MSCI ESG Rating Upgraded to AA, Recognized as a Global Leader
- GenScript Biotech Corporation Reports FY 2024 Results
- The GenScript Biotech Global Forum Makes a Strong Debut in Europe, Highlighting Breakthroughs in Cell and Gene Therapy Development
- GenScript Biotech Sets Up New Operations and Logistics Hub in Sydney, Australia
- GenScript Biotech Corporation (GNNSF) Q2 2024 Earnings Call Transcript
Your note
Sign in to keep a note on GNNSF — it syncs with the Stock Master app.